By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
TxCell Announces Revenue And Cash Position As Of December 31, 2015 2/2/2016 1:50:41 PM
TxCell Admitted To The SRD (Deferred Settlement Service) “Long-Only” 12/23/2015 6:08:29 AM
TxCell Implements A Two-Year, No-Minimum-Draw Standby Equity Facility (SEF(R)) 12/22/2015 11:29:49 AM
TxCell Re-Acquires Full Rights To Its Lead Product Ovasave 12/2/2015 12:49:33 PM
TxCell Strengthens Management Team With Five New Vice Presidential Appointments 11/30/2015 12:52:55 PM
TxCell: Financial Information For The 3rd Quarter Of 2015 11/5/2015 10:59:08 AM
TxCell Secures Key CAR-Treg Patent Through Exclusive Option Agreement With Yeda Research and Development Company Ltd., The Commercial Arm Of World's Recognized Weizmann Institute of Science 11/2/2015 1:09:56 PM
TxCell To Present Its Cellular Immunotherapy Developments At Leading Investor Conferences 9/28/2015 10:59:15 AM
TxCell: Financial Results For The First Half Of 2015 9/22/2015 2:22:56 PM
TxCell Granted U.S. Orphan Drug Designation For Col-Treg In The Treatment Of Chronic Non-Infectious Uveitis 9/14/2015 9:25:17 AM